股票 › INBX
英伯克斯生物科技 INBX
美股市值排名 #3072
$84.52 +$4.24 (+5.28%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $82.41 -2.50%
开盘$80.68
昨收$80.28
当日区间$79.47 – $85.58
成交量220.2K
市值$1.24B
市盈率（TTM）–
股息率–
INBX 相关新闻
匹配 Inhibrx Biosciences 或代码 INBX 的头条新闻，按最新排序。
- Analysts Offer Insights on NA Companies: Evommune, Inc. (EVMN), Inhibrx Biosciences Inc (INBX) and Circle Internet Group, Inc. Class A (CRCL)
- H.C. Wainwright Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $245
- LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $230
- H.C. Wainwright Initiates Inhibrx Biosciences(INBX.US) With Buy Rating, Announces Target Price $245
- Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $325
- Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $325 正面
- LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $230 正面
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Apellis Pharmaceuticals (APLS), Fractyl Health, Inc. (GUTS) and Inhibrx Biosciences Inc (INBX)
- LifeSci Capital Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $200
- LifeSci Capital Initiates Inhibrx Biosciences(INBX.US) With Buy Rating, Announces Target Price $200
- Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Raises Target Price to $300 正面
- Stifel Initiates Inhibrx Biosciences(INBX.US) With Buy Rating, Announces Target Price $150
- Stifel Maintains Inhibrx Biosciences(INBX.US) With Buy Rating, Maintains Target Price $325
- Citizens JMP Maintains Inhibrx Biosciences(INBX.US) With Hold Rating
- JMP Securities Maintains Inhibrx Biosciences(INBX.US) With Hold Rating
暂无评论——快来第一个聊聊 INBX。
登录后参与讨论。